In today’s fast-paced and competitive biotechnology landscape, control and speed define success for companies and core labs ...
Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, and Nitto Denko Avecia, Inc. a leading contract development and ...
Dublin, Oct. 03, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market Report by Product, Application, End Use, and Region 2025-2033" has been added to ResearchAndMarkets.com's offering. The ...
Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...
Growing Importance of Peptide & Oligonucleotide TherapeuticsPeptides and oligonucleotides are transforming modern medicine.
A University of Alberta research team is shedding much-needed light on cancer cachexia, a severe muscle-wasting syndrome ...
Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...
Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...
A University of Alberta research team is shedding much-needed light on cancer cachexia, a severe muscle-wasting syndrome linked to up to a third of ...
India’s CRDMO sector, currently valued at $3–3.5 billion, accounts for just 2–3% of the $140–145 billion global market. But ...
Researchers have unveiled a new DNA-based therapy that silences the PCSK9 gene to lower cholesterol without statin side effects. Early results show dramatic reductions in cholesterol levels, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback